Skip to main content

Sequenom Increases Private Placement by $3M

NEW YORK, April 3 (GenomeWeb News) - Sequenom said today that that its previously announced private stock placement has been increased by $3 million to $33 million.

 

The company said the increase comes with the addition of Siemens Venture Capital to the list of investors taking part in the placement.

 

Under the terms of the increased transaction, which remains subject to shareholder approval and other closing conditions, Sequenom will issue 60 million shares of common stock and 36 million warrants exercisable at $.70 per share.

 

The transaction is expected to close by May 31, the company said. Net proceeds from the transaction will be used for general working capital needs.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.